Cambridge, United Kingdom

Chris Steele

USPTO Granted Patents = 7 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
7 patents (USPTO):

Title: Chris Steele: Innovator in Neuromuscular Disease Treatment

Introduction

Chris Steele is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of neuromuscular diseases. With a total of 7 patents to his name, Steele's work focuses on innovative compounds that have the potential to improve the lives of those affected by conditions such as Duchenne Muscular Dystrophy (DMD).

Latest Patents

One of Steele's latest patents involves pyridazinone compounds and their uses. These substituted pyridazinone compounds, along with their conjugates and pharmaceutical compositions, are designed for the treatment of neuromuscular diseases, including DMD. The disclosed compounds are particularly useful in treating DMD and modulating inflammatory inhibitors such as IL-1, IL-6, or TNF-α. This innovative approach highlights Steele's commitment to advancing medical treatments for debilitating conditions.

Career Highlights

Throughout his career, Chris Steele has worked with notable companies in the pharmaceutical industry, including Edgewise Therapeutics, Inc. and Edgewise Therapeutics, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.

Collaborations

Steele has collaborated with several professionals in his field, including Kevin W. Hunt and Kevin Koch. These collaborations have likely enriched his research and development efforts, fostering an environment of innovation and shared knowledge.

Conclusion

Chris Steele is a dedicated inventor whose work in the field of neuromuscular disease treatment is making a significant impact. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes for patients with DMD and other related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…